UETeM Lab
  • Home
  • Opportunities
  • News
    • Relevant papers
    • Press articles
    • Upcoming lipodystrophy events
  • Projects
  • Publications
  • Team
  • Collaborations
  • Links
  • Contact
  • LipoDDx

2023 ECLip Annual Meeting SAVE THE DATE!!!

1 Jun, 2022

2023 ECLip Annual Meeting

September, 28-29th
CENTRO CONGRESSI LE BENEDETTINE
Piazza S. Paolo a Ripa D'Arno, 16
Pisa, Italia

Congratulations to Prof. Joaquín Lado-Abeal, chief of endocrinology

12 May, 2022
We are proud to announce that the UC Davis Department of Internal Medicine in Sacramento has announced the appointment of Jose Joaquin Lado-Abeal as chief of the Division of Endocrinology, Diabetes and Metabolism. Congratulations!

Link

Unlocking the metabolic code of lipodystrophy

12 May, 2022

Prof. David Araújo-Vilar actively participated in the Global Summit event "Unlocking the metabolic code of lipodystrophy" organized by Amryt Pharmaceuticals on May 3 and 4, 2022 in Egham, Surrey (United Kingdom).

Program



A new PhD in the UETeM research group !

16 Feb, 2022

Congratulations to Antía Fernández-Pombo for successfully defending her doctoral thesis!

From left to right:
- Prof. Miguel A Martínez Olmos,
head of the Endocrinology and Nutrition Service of the University Clinical Hospital of Santiago de Compostela.
- Prof. David Araújo-Vilar, Associate Professor of Medicine at USC Specialist in Endocrinology and Nutrition Responsible of the Lipodystrophy Unit
- Dr. Antía Fernández-Pombo, Specialist in Endocrinology and Nutrition
- Dr. José Cocho de Juan, head of the Metabolopathies laboratory section of the University Clinical Hospital of Santiago de Compostela.


Twitter link

  

Natural course and comorbidities of lipodystrophy syndromes in Spain

Lipodystrophy syndromes constitute a heterogeneous group of rare diseases characterised by the selective loss of adipose tissue, which leads to impaired insulin signalling and other cellular functions, giving rise to metabolic complications that contribute to higher mortality rates in these patients. However, the exact natural history of these syndromes is not well documented, leading to long delays in diagnosis or misdiagnosis. This thesis constitutes the first real-life study with the objetive of evaluating the natural course and associated comorbidities througout the lives of patients with generalised and partial lipodystrophy (both acquired and congenital) in Spain in an effort to contribute to increasing knowledge of these rare syndromes.

David Araújo-Vilar receives the E-nnova Health 21 Award

11 Nov, 2021

David Araújo-Vilar receives the E-nnova Health 21 award for the project "Artificial intelligence diagnosis of rare lipodystrophies".

Link



Lipodystrophy master class for Middle East countries

28 May, 2021

Prof. David Araújo-Vilar participated today in the Lipodystrophy master class for Middle East countries.

The event was organized by the Arab Society for Paediatric Endocrinology and Diabetes.


Dr. Antía Fernández-Pombo wins the Award for Excellence in MIR training in Endocrinology and Nutrition

14 Oct, 2020
Dr. Antía Fernández Pombo, member of the @uetemlab, has been awarded by the Foundation of the Spanish Society of Endocrinology and Nutrition with the Award for Excellence in MIR training in Endocrinology and Nutrition. So proud of you! Congrats Antía! @cimususc @UniversidadeUSC @sociedadSEEN

 

New UETeM publication: LipoDDx

11 Apr, 2020
LipoDDx: a mobile application for identification of rare lipodystrophy syndromes.
Araújo-Vilar D, Fernández-Pombo A, Rodríguez-Carnero G, Martínez-Olmos MÁ, Cantón A, Villar-Taibo R, Hermida-Ameijeiras Á, Santamaría-Nieto A, Díaz-Ortega C, Martínez-Rey C, Antela A, Losada E, Muy-Pérez AE, González-Méndez B, Sánchez-Iglesias S.
Orphanet J Rare Dis
. 2020; 15(1): 81.
doi: 10.1186/s13023-020-01364-1

LipoDDx: candidate for the "Redacción Médica" Awards in Galicia

18 Feb, 2020

The LipoDDx app has been chosen as a candidate for the "Redacción Médica" Awards in Galicia in the Technological Contribution category.

Link



First Lipodystrophies Symposium in Portugal

20 Jan, 2020
Members of the UETeM participated in the 1st Lipodystrophies Symposium in Porto (Portugal, 16-18 January)



Prof. David Araújo-Vilar participates in the 40th SEMI Congress

28 Nov, 2019
El Prof. David Araújo-Vilar participa en la mesa redonda "Actualizaciones terapéuticas en diabetes, obesidad y nutrición" del 40º Congreso Nacional de la Sociedad Española de Medicina Interna (SEMI) en Barcelona con la ponencia "Lipodistrofias parciales: un reto en el diagnóstico".


Antía Fernández Pombo wins the Best Oral Clinical Communication at SGENM2019

16 Nov, 2019
Antía Fernández Pombo, member of the UETeM group, wins the prize for the best oral clinical communication at the 32nd Congress of the Galician Society of Endocrinology, Metabolism and Nutrition. Well done Antía!

@SoGENM
#SGENM2019
@cimususc
@UniversidadeUSC


Official presentation of LipoDDx

29 Oct, 2019
Official presentation of LipoDDx: new APP for lipodystrophies.

Tuesday, December 10, 2019, 1:30 p.m.

University Clinical Hospital of Santiago de Compostela


@UniversidadeUSC

@cimususc

@AELIP_

@campusvida


ECLip2019: a success!

19 Oct, 2019
#ECLip2019 has been a success! International researchers, patients and patient associations working together to advance in the field of lipodystrophies and improve the quality of life of patients.

Thanks to all the speakers, attendants, Creer center in Burgos, Asociación de Familiares y Afectados de Lipodistrofias, Lipodystrophy UK and Lipodystrophy United.

We can't wait to meet again in Cambridge on October 14-15, 2020 !

ECLip 2019 Gallery: https://www.eclip-web.org/meetings/2019/gallery/

Prof. David Araújo-Vilar, elected President of the European Consortium of Lipodystrophies (ECLip)

19 Oct, 2019
Prof. David Araújo-Vilar has just been elected president of the European Consortium of Lipodystrophies (ECLip), an excellence network of clinical and basic research in rare lipodystrophies that brings together 51 groups from 22 countries in both Europe, United States, Egypt and United Arab Emirates. His appointment came as part of the ECLip General Assembly hold recently in Burgos, which addressed the renewal of the board of directors of the Consortium in addition to holding its fourth meeting.

Goberning Board of ECLip: https://www.eclip-web.org/information/executive-board/


Her Majesty The Queen receives in audience Prof. David Araújo-Vilar along with the experts of the FEDER advisory committee

19 Jul, 2019

Prof. David Araújo Vilar, along with the other experts of the FEDER advisory committee, is received in audience by Her Majesty The Queen at the Palacio de la Zarzuela.

Link


UETeM attended the workshops organized by Merlin-ICT and Bioga

9 Jul, 2019
UETeM participated in the 4 workshops, organized by Bioga Galicia and Merlin-ict, that aimed to stimulate the transfer of research results to the market.


UETeM participated in the Lab Leadership Management Workshop

9 Jul, 2019
Young PIs and group leaders from CiMUS and IDIS successfully participated in the Lab Leadership Management Workshop in Santiago de Compostela (25-28 June, 2019)



UETeM participates in the Merlin Project

12 May, 2019

UETeM Lab participates in the Merlin Project to promote effective models for the successful commercialization of its R & D activity. Organized by Bioga Galicia, Merlin-ict, GAIN Axencia galega de innovación.


Prof. David Araújo-Vilar and AELIP visit the National Institute of Child Health in Peru

12 Apr, 2019
Prof. David Araújo-Vilar and AELIP visited the National Institute of Child Health in Peru and held meetings with the Department of Genetics and the Hospital management to implement a study of Berardinelli-Seip Syndrome in Piura and help preventing this rare disease.


 

Load more

Recent Posts

  • 2023 ECLip Annual Meeting SAVE THE DATE!!!
    1 Jun, 2022
  • A Novel, Heterozygous BSCL2 Variant in Association With Early-Onset Epileptic Encephalopathy
    14 May, 2022
  • Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)
    14 May, 2022
  • Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network
    14 May, 2022
  • Metreleptin for the treatment of lipodystrophy: leading the way among novel therapeutics for this unmet clinical need
    14 May, 2022
  • Seipin forms a flexible cage at lipid droplet formation sites
    14 May, 2022
  • Clinical Effects of Sodium-Glucose Transporter Type 2 Inhibitors in Patients With Partial Lipodystrophy
    14 May, 2022
2019 UETeM Laboratory